HomeInsightsPE

Vivanza Biosciences Ltd PE Ratio

Vivanza Biosciences Ltd PE Ratio

stocks purchased

₹ 0.7 Cr

Volume Transacted

(Dec 12, 2024)

stocks purchased

1769.9 K

Stocks Traded

(Dec 12, 2024)

Last Updated on: Dec 13, 2024

Image

Vivanza Biosciences Ltd

NSE: VIVANZABIOSCI

PE

187.5

Last updated on: Dec 13, 2024

Key Highlights

  • The P/E Ratio of Vivanza Biosciences Ltd is 187.5 as of 13 Dec 9.00 AM .
  • The P/E Ratio of Vivanza Biosciences Ltd changed from 687.4 on March 2021 to 48.5 on March 2024 . This represents a CAGR of -48.46% over 4 years.
  • The Latest Trading Price of Vivanza Biosciences Ltd is ₹ 3.75 as of 12 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Vivanza Biosciences Ltd

No data available

Company Fundamentals for Vivanza Biosciences Ltd

No data available

Image

Vivanza Biosciences Ltd

NSE: VIVANZABIOSCI

Share Price

₹ 3.75

0.20 (5.63%)

stock direction

Last updated on: Dec 12, 2024

Market Price of Vivanza Biosciences Ltd

1M

1Y

3Y

5Y

Monitoring Vivanza Biosciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 Dec 20243.75
11 Dec 20243.55
10 Dec 20243.47
09 Dec 20243.34
06 Dec 20243.59
05 Dec 20243.54
04 Dec 20243.66
03 Dec 20243.85
02 Dec 20243.79
29 Nov 20243.79

SWOT Analysis Of Vivanza Biosciences Ltd

Strength

2

S

Weakness

3

W

Opportunity

1

O

Threats

0

T

BlinkX Score for Vivanza Biosciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Vivanza Biosciences Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Vivanza Biosciences Ltd18715
Sun Pharmaceuticals Industries Ltd384,32,948
Divis Laboratories Ltd861,57,873
Cipla Ltd251,16,809
Torrent Pharmaceuticals Ltd641,12,638
Mankind Pharma Ltd501,06,198

Key Valuation Metric of Vivanza Biosciences Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Vivanza Biosciences Ltd

No data available

* All values are in crore

Historical Revenue of Vivanza Biosciences Ltd

No data available

* All values are in crore

Historical EBITDA of Vivanza Biosciences Ltd

No data available

* All values are in crore

Historical Net Profit of Vivanza Biosciences Ltd

No data available

* All values are in crore

Historical Dividend Payout of Vivanza Biosciences Ltd

No data available

* All values are in %

About Vivanza Biosciences Ltd

  • Vivanza Biosciences Ltd (Previously known Ivee Injectaa Limited) was established in March, 1982 as a Private Limited Company and was converted into a Public Limited Company in May, 1992.
  • Head quartered in Gujarat, India, the Company came into existence in April 2016 with the sole aim to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system. The Company is presently engaged in the business of Pharmaceutical Products and Pharma Products. However Competition in the industry is continuously increasing.
  • New technology is being adopted and steps are taken to improve the manufacturing capacity of the Company.
  • Further, the Company has also set its vision in global market to supply and execute turnkey pharmaceutical units. The company undertook an expansion-cum-diversification programme to increase its capacity from 18 lac pa to 54 lac pa.

Vivanza Biosciences Ltd News Hub

News

Vivanza Biosciences consolidated net profit declines 44.90% in the June 2024 quarter

Net profit of Vivanza Biosciences declined 44.90% to Rs 0.27 crore in the quarter ended Ju...

Read more

2024-08-09 00:00:00

News

Vivanza Biosciences to announce Quarterly Result

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 8 Augu...

Read more

2024-08-03 00:00:00

News

Vivanza Biosciences to declare Quarterly Result

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 17 Oct...

Read more

2024-10-11 00:00:00

News

Vivanza Biosciences consolidated net profit declines 92.31% in the September 2024 quarter

Net profit of Vivanza Biosciences declined 92.31% to Rs 0.02 crore in the quarter ended Se...

Read more

2024-10-18 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Vivanza Biosciences Ltd

What is the current PE Ratio of Vivanza Biosciences Ltd?

The Current PE Ratio of Vivanza Biosciences Ltd is 187.5 as on 13 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 13 Dec 2024.

What was the PE Ratio of Vivanza Biosciences Ltd last year?

The PE Ratio of Vivanza Biosciences Ltd was 125.33 last year, now the PE ratio is 187.5, showing a year-on-year growth of 49.6%.

What does the PE Ratio of Vivanza Biosciences Ltd indicate about its stock?

The PE Ratio of Vivanza Biosciences Ltd is 187.5. This ratio indicates that investors are willing to pay 187.5 times the earnings per share for each share of Vivanza Biosciences Ltd.

What is the PE Ratio Growth of Vivanza Biosciences Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Vivanza Biosciences Ltd grew by 49.6% whereas, the EPS ratio grew by -100.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions